1 October 2026 Farmak International Reaches Key R&D Milestone in Paliperidone 1-Monthly LAI Development Farmak International has reached an important R&D milestone in its development program for of Paliperidone 1-monthly long-acting injection (LAI)
11 September 2026 Farmak International Completes 17 Launches Across 9 Markets This Summer From June to August 2026, Farmak International completed 17 product launches and re-launches across 9 countries.
30 July 2026 ICM Farmak Expands Its Authorized Activities in Spain ICM Farmak S.L.U., Farmak International’s sterile injectables manufacturing site in Spain, has received an updated certificate from the Spanish Agency of Medicines and Medical Devices (AEMPS), reflecting an expanded scope of authorized activities.
30 July 2026 ICM Farmak Expands GMP-Certified Capabilities with In-House Sterility Testing ICM Farmak S.L.U., Farmak International’s manufacturing site in Spain, has received authorization from the Spanish Agency of Medicines and Medical Devices (AEMPS) to perform microbiological sterility testing within its own quality control laboratories.
9 July 2026 Farmak International Receives Silver Sustainability Booth Design Award at CPHI SEA 2026 Farmak International is pleased to announce that our exhibition stand at CPHI South East Asia 2026 received the Sustainability Booth Design Award, Silver level, in recognition of our use of reusable elements and sustainable design solutions.
